Functionality and Usability Reduce Lead Times – the Reason CRO Aptus Clinical Chose Viedoc

Functionality, API integration capabilities and overall usability were the key criteria when Clinical Contract Research Organization Aptus Clinical chose Viedoc as their new EDC system last year.

“Viedoc was our first choice both when looking at the technical specification and more hands-on demonstrations. Now we can be completely self-sufficient in building our studies, which greatly reduces our lead times,” says Paul Blaney, Digital Health Lead at Aptus Clinical.

With a 20-year track record of delivering Phase I-III clinical trials, Paul Blaney knows what it takes to be successful in this area. He and his Aptus Clinical colleagues evaluated six different EDC systems in three phases, where Viedoc scored the highest in each phase.

“Naturally there’s always some growing problems to work out in the beginning but overall Viedoc fulfills all our needs, and we’re looking forward to working together for a long time to come.”

One of the deciding factors was Viedoc’s API integration capabilities.

“It’s vital for us to be able to seamlessly import and export XML and ODM files from our local systems and Viedoc’s functionality is excellent in that regard. Working with several separate systems is always a risk factor but with Viedoc’s API, it’s a non-issue.” 

Aptus Clinical has now been up and running with Viedoc for some time, says Paul and summarizes: “The combination of high functionality and user-friendliness is what makes Viedoc stand out”.

About Aptus Clinical
Founded in 2013, Aptus Clinical is a specialist UK-based Clinical Contract Research Organization (CRO) with particular expertise in oncology, rare diseases and advanced, cell and gene therapies. Aptus Clinical is part of iMATCH, a Manchester-based consortium which is one of only three centres in the UK to be awarded funding by Innovate UK to coordinate scale-up of advanced therapies for a range of debilitating conditions.